Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Wahed Invest LLC

Wahed Invest LLC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 6.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,042 shares of the medical equipment provider's stock after buying an additional 523 shares during the period. Intuitive Surgical makes up 0.8% of Wahed Invest LLC's holdings, making the stock its 24th biggest position. Wahed Invest LLC's holdings in Intuitive Surgical were worth $4,720,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Principal Financial Group Inc. grew its position in Intuitive Surgical by 1.5% in the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider's stock worth $295,938,000 after acquiring an additional 9,194 shares during the period. World Investment Advisors LLC acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth about $228,000. Arvest Bank Trust Division purchased a new stake in Intuitive Surgical in the 3rd quarter valued at about $260,000. Destination Wealth Management lifted its position in Intuitive Surgical by 4.1% in the third quarter. Destination Wealth Management now owns 770 shares of the medical equipment provider's stock valued at $378,000 after buying an additional 30 shares during the last quarter. Finally, Synovus Financial Corp boosted its stake in Intuitive Surgical by 1.1% during the third quarter. Synovus Financial Corp now owns 2,572 shares of the medical equipment provider's stock worth $1,264,000 after buying an additional 28 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

NASDAQ ISRG traded up $2.40 on Monday, reaching $531.82. The stock had a trading volume of 1,374,627 shares, compared to its average volume of 1,624,418. The stock has a market cap of $190.61 billion, a P/E ratio of 82.97, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 12-month low of $379.67 and a 12-month high of $616.00. The business's 50-day moving average price is $504.32 and its 200 day moving average price is $534.38.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period last year, the business posted $1.50 EPS. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. Royal Bank of Canada reduced their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Wells Fargo & Company boosted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Erste Group Bank lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 17th. Evercore ISI cut their price objective on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a report on Wednesday, April 23rd. Finally, Truist Financial lowered their target price on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $598.95.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 269 shares of the company's stock in a transaction on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares of the company's stock, valued at $1,936,380. This represents a 7.58 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the business's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,313 shares of company stock worth $17,229,143 over the last ninety days. 0.70% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.